Cargando…
Fluoxetine: a review on evidence based medicine
BACKGROUND: Fluoxetine was the first molecule of a new generation of antidepressants, the Selective Serotonin Re-uptake Inhibitors (SSRIs). It is recurrently the paradigm for the development of any new therapy in the treatment of depression. Many controlled studies and meta-analyses were performed o...
Autores principales: | Rossi, Andrea, Barraco, Alessandra, Donda, Pietro |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC356924/ https://www.ncbi.nlm.nih.gov/pubmed/14962351 http://dx.doi.org/10.1186/1475-2832-3-2 |
Ejemplares similares
-
FLUOXETINE AND PARESTHESIAS
por: Pfizer, N., et al.
Publicado: (2001) -
Serum fluoxetine and norfluoxetine levels support the safety of fluoxetine in overdose
por: Pope, Stephanie, et al.
Publicado: (2016) -
Factors Influencing Depression Endpoints Research (FINDER): baseline results of Italian patients with depression
por: Grassi, Luigi, et al.
Publicado: (2009) -
Fluoxetine-induced alteration of murine gut microbial community structure: evidence for a microbial endocrinology-based mechanism of action responsible for fluoxetine-induced side effects
por: Lyte, Mark, et al.
Publicado: (2019) -
SEIZURE FOLLOWING FLUOXETINE
por: Sanjay, C.S., et al.
Publicado: (1993)